Antibody therapeutics
Adagene discovers and develops engineered antibody drugs for cancer and other diseases, mainly through its own pipeline of experimental medicines and its antibody platform.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Adagene is a biotechnology company that designs and develops antibody-based cancer medicines. Its main work is to create therapeutic antibodies and move the most promising ones into clinical testing, rather than selling a finished drug portfolio today. The company’s science centers on making antibodies that are active only when they reach the right tumor environment, which is meant to improve how the drugs target cancer cells.
Its customers are mainly pharmaceutical partners, and eventually patients and doctors if its drug candidates win approval. Adagene makes money through collaboration deals, research partnerships, licensing arrangements, and, in the longer run, could earn product sales or royalties if any of its drug programs reach the market. That means the business is built around drug discovery and development, not manufacturing a large consumer product.
What makes Adagene different is its focus on precision antibody engineering. Instead of inventing a broad range of medicines, it concentrates on one technical problem: making powerful antibodies safer and more selective by controlling when and where they turn on. In the biotech value chain, that puts Adagene in the early-stage research and development role, where its main assets are its platform, its drug candidates, and its partnerships with larger drug companies.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more